Recro Pharma, Inc. (REPH) Stock Overview
Explore Recro Pharma, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Recro Pharma, Inc. (REPH)
Key Financials
Key Financials
Market Cap
177.4M
P/E Ratio
-14.99
EPS (TTM)
$-0.26
ROE
-0.22%
REPH Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Recro Pharma, Inc. (REPH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -14.99 and a market capitalization of 177.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.